DTC Healthcare with 23andMe CEO Anne Wojcicki
Motley Fool Money
Intro
This chapter delves into 23andMe's groundbreaking method of providing consumers with direct access to their health data, bypassing traditional medical channels. The discussion also covers the company's stock performance post-IPO and the broader implications of genetic testing in personalized medicine.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
